Multiple sclerosis MS patients vs -0.68 (-0.82, YES ADDIN Liu46 2012 SUA level (umol/L) 8 1,037 556 SMD Random (MS) controls EN.CITE Multiple sclerosis MS patients vs -0.40 (-0.73, Wang47 2016 SUA level (μmol/L) 10 2,216 1,308 SMD Random (MS) 47 Neruomyelistsopticis NMO patients vs -0.85 (-1.24, Wang47 2016 3 1,137 229 SMD Random SUA level (μmol/L) (NMO) 0.46) MS+NMO patients -0.52 (-0.81, Wang47 2016 MS and NMO SUA level (μmol/L) 13 2,445 1,537 SMD Random vs control Abraham ADDIN EN.CITE Amyotrophic lateral ALS patients vs 2014 SUA level ( mg/dl) 3 826 311 Hedge's G NA 0.84 (NA, NA) sclerosis (ALS) controls Flatow ADDIN EN.CITE Chronic Schizophrenia 2013 Schizophrenia SUA level (mg/dl) 3 241 103 Hedge's G Random p=0.15 (Chronic) patients vs controls
Liu46 2012 Multiple sclerosis (MS) MS patients vs controls SUA level (umol/L) 8 1,037 556 SMD Random -0.68 (-0.82, YES ADDIN EN.CITE 47 Wang47 2016 Multiple sclerosis (MS) MS patients vs SUA level (μmol/L) 10 2,216 1,308 SMD Random -0.40 (-0.73, Wang47 2016 Neruomyelistsopticis (NMO) NMO patients vs SUA level (μmol/L) 3 1,137 229 SMD Random -0.85 (-1.24, Wang47 2016 MS and NMO MS+NMO patients vs control SUA level (μmol/L) 13 2,445 1,537 SMD Random -0.52 (-0.81, Abraham ADDIN EN.CITE 2014 Amyotrophic lateral sclerosis (ALS) ALS patients vs controls SUA level ( mg/dl) 3 826 311 Hedge's G NA 0.84 (NA, NA) Flatow ADDIN EN.CITE 2013 Schizophrenia (Chronic) Chronic Schizophrenia patients vs controls SUA level (mg/dl) 3 241 103 Hedge's G Random p=0.15 0.46)
Supplementary%20material_v7%20-%20Final-2.docx